AAAAAA
Results: 1-25/28
Authors:
Braun, J
de Keyser, F
Brandt, J
Mielants, H
Sieper, J
Veys, E
Citation: J. Braun et al., New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy, CURR OP RH, 13(4), 2001, pp. 245-249
Authors:
Cuvelier, C
Demetter, P
Mielants, H
Veys, EM
De Vos, M
Citation: C. Cuvelier et al., Interpretation of ileal biopsies: morphological features in normal and diseased mucosa, HISTOPATHOL, 38(1), 2001, pp. 1-12
Authors:
Van Damme, N
De Keyser, F
Demetter, P
Baeten, D
Mielants, H
Verbruggen, G
Cuvelier, C
Veys, EM
De Vos, M
Citation: N. Van Damme et al., The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome, CLIN EXP IM, 125(3), 2001, pp. 383-390
Authors:
Baeten, D
Kruithof, E
Van den Bosch, F
Mielants, H
Veys, EM
De Keyser, F
Citation: D. Baeten et al., Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: Comment on the article by Baeten et al - Reply, ARTH RHEUM, 44(12), 2001, pp. 2938-2939
Authors:
Baeten, D
Kruithof, E
Van den Bosch, F
Demetter, P
Van Damme, N
Cuvelier, C
De Vos, M
Mielants, H
Veys, EM
De Keyser, F
Citation: D. Baeten et al., Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy - Histologic findings in eight patients from an open-label pilot study, ARTH RHEUM, 44(1), 2001, pp. 186-195
Authors:
Baeten, D
Van Damme, N
Van den Bosch, F
Kruithof, E
De Vos, M
Mielants, H
Veys, EM
De Keyser, F
Citation: D. Baeten et al., Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNF alpha, ANN RHEUM D, 60(8), 2001, pp. 750-755
Authors:
Van Damme, N
De Vos, M
Baeten, D
Demetter, P
Mielants, H
Verbruggen, G
Cuvelier, C
Veys, EM
De Keyser, F
Citation: N. Van Damme et al., Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy, ANN RHEUM D, 60(5), 2001, pp. 495-499
Authors:
Van den Bosch, F
Baeten, D
Kruithof, E
De Keyser, F
Mielants, H
Veys, EM
Citation: F. Van Den Bosch et al., Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha, ANN RHEUM D, 60, 2001, pp. III33-III36
Authors:
Demetter, P
De Vos, M
Van Damme, N
Baeten, D
Elewaut, D
Vermeulen, S
Mareel, M
Bullock, G
Mielants, H
Verbruggen, G
De Keyser, F
Veys, EM
Cuvelier, CA
Citation: P. Demetter et al., Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosabut reduced expression in ulcer associated cell lineage, AM J CLIN P, 114(3), 2000, pp. 364-370
Authors:
De Keyser, F
Van Damme, N
De Vos, M
Mielants, H
Veys, EM
Citation: F. De Keyser et al., Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation, INFLAMM RES, 49(2), 2000, pp. 47-54
Authors:
de Vlam, K
Van de Wiele, C
Mielants, H
Dierckx, RA
Veys, EM
Citation: K. De Vlam et al., Is Tc-99m human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis?, CLIN EXP RH, 18(3), 2000, pp. 379-382
Authors:
de Vlam, K
Mielants, H
Verstraete, KL
Veys, EM
Citation: K. De Vlam et al., The zygapophyseal joint determines morphology of the enthesophyte, J RHEUMATOL, 27(7), 2000, pp. 1732-1739
Authors:
de Vlam, K
Mielants, H
Cuvelier, C
De Keyser, F
Veys, EM
De Vos, M
Citation: K. De Vlam et al., Spondyloarthropathy is underestimated in inflammatory bowel disease: Prevalence and HLA association, J RHEUMATOL, 27(12), 2000, pp. 2860-2865
Authors:
Van den Bosch, F
Kruithof, E
De Vos, M
De Keyser, F
Mielants, H
Citation: F. Van Den Bosch et al., Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms, LANCET, 356(9244), 2000, pp. 1821-1822
Authors:
Van Damme, N
Baeten, D
De Vos, M
Demetter, P
Elewaut, D
Mielants, H
Verbruggen, G
Cuvelier, C
Veys, EM
De Keyser, F
Citation: N. Van Damme et al., Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers, J IMMUNOL M, 236(1-2), 2000, pp. 27-35
Authors:
Van den Bosch, F
Kruithof, E
Baeten, D
De Keyser, F
Mielants, H
Veys, EM
Citation: F. Van Den Bosch et al., Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study, ANN RHEUM D, 59(6), 2000, pp. 428-433
Authors:
Demetter, P
Baeten, D
De Keyser, F
De Vos, M
Van Damme, N
Verbruggen, G
Vermeulen, S
Mareel, M
Elewaut, D
Mielants, H
Veys, EM
Cuvelier, CA
Citation: P. Demetter et al., Subclinical gut inflammation in spondyloarthropathy patients is associatedwith upregulation of the E-cadherin/catenin complex, ANN RHEUM D, 59(3), 2000, pp. 211-216
Authors:
Baeten, D
Demetter, P
Cuvelier, C
Van den Bosch, F
Kruithof, E
Van Damme, N
Verbruggen, G
Mielants, H
Veys, EM
De Keyser, F
Citation: D. Baeten et al., Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity, ANN RHEUM D, 59(12), 2000, pp. 945-953
Authors:
Vanneuville, B
Janssens, A
Lemmerling, M
de Vlam, K
Mielants, H
Veys, EM
Citation: B. Vanneuville et al., Non-Hodgkin's lymphoma presenting with spinal involvement, ANN RHEUM D, 59(1), 2000, pp. 12-14
Authors:
Calin, A
Nakache, JP
Gueguen, A
Zeidler, H
Mielants, H
Dougados, M
Citation: A. Calin et al., Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?, RHEUMATOLOG, 38(9), 1999, pp. 878-882
Authors:
Zmierczak, H
Goemaere, S
Mielants, H
Verbruggen, G
Veys, EM
Citation: H. Zmierczak et al., Candida glabrata arthritis: Case report and review of the literature of candida arthritis, CLIN RHEUMA, 18(5), 1999, pp. 406-409
Authors:
Kruithof, E
Elewaut, D
Naeyaert, JM
Praet, M
Mielants, H
Veys, EM
De Keyser, F
Citation: E. Kruithof et al., Polyarteritis nodosa mimicking polymyalgia rheumatica, CLIN RHEUMA, 18(3), 1999, pp. 257-260
Authors:
de Vlam, K
Mielants, H
Veys, EM
Citation: K. De Vlam et al., Involvement of the zygapophyseal joint in ankylosing spondylitis: Relationto the bridging syndesmophyte, J RHEUMATOL, 26(8), 1999, pp. 1738-1745
Authors:
Spoorenberg, A
van der Heijde, D
de Klerk, E
Dougados, M
de Vlam, K
Mielants, H
van der Tempel, H
van der Linden, S
Citation: A. Spoorenberg et al., A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis, J RHEUMATOL, 26(4), 1999, pp. 961-965
Authors:
Calin, A
Nakache, JP
Gueguen, A
Zeidler, H
Mielants, H
Dougados, M
Citation: A. Calin et al., Outcome variables in ankylosing spondylitis: Evaluation of their relevanceand discriminant capacity, J RHEUMATOL, 26(4), 1999, pp. 975-979